Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
The Department for Promotion of Industry and Internal Trade (DPIIT) has granted approval for the…
Some countries are given nicknames because of their unique qualities. One such nickname is "Switzerland…
In a significant move to enhance ease of doing business, the Securities and Exchange Board…
John Prescott, one of Britain’s most recognized politicians and a champion of the working class,…
Kenyan President William Ruto announced on November 21, 2024, the cancellation of multimillion-dollar deals with…
At The Hindu AI Summit 2024, Kumar Jayant, Additional Chief Secretary of the Department of…